Lomaira, a low-dose phentermine hydrochloride formulation, is indicated for short-term weight management [1]. The average weight loss observed in clinical trials with lomaira, when used as part of a comprehensive weight management program including diet and exercise, was 4.4% of body weight at six weeks [1]. This was compared to 1.7% weight loss in the placebo group over the same period [1].
What is Lomaira approved for?
Lomaira is approved for short-term management of obesity in patients [1]. It is intended for individuals with a body mass index (BMI) of 30 kg/m² or greater, or for those with a BMI of 27 kg/m² or greater who have other risk factors or comorbidities associated with obesity [1]. The medication is meant to be used in conjunction with a reduced-calorie diet and increased physical activity [1].
How does Lomaira work for weight loss?
Lomaira contains phentermine hydrochloride, which is a sympathomimetic amine that acts as an appetite suppressant [1]. It is believed to stimulate the central nervous system to reduce appetite [1]. The low-dose formulation of lomaira allows for a different dosing regimen compared to higher-dose phentermine products [1].
What are the potential side effects of Lomaira?
Common side effects associated with phentermine, including lomaira, can include dry mouth, constipation, insomnia, and nervousness [1]. More serious side effects may involve cardiovascular issues, such as increased blood pressure and heart rate, and psychiatric symptoms [1]. Patients with a history of heart disease, high blood pressure, or psychiatric disorders should discuss these risks with their healthcare provider [1].
How does Lomaira compare to other weight loss medications?
Lomaira is a prescription medication containing phentermine, a stimulant appetite suppressant [1]. Other weight loss medications work through different mechanisms. For instance, some medications aim to reduce fat absorption (like orlistat), while others target gut hormones or brain pathways involved in appetite and satiety. The specific efficacy and side effect profiles vary significantly between different weight loss drugs.
When is Lomaira prescribed?
Lomaira is prescribed as a short-term treatment for weight management [1]. It is typically used for individuals who are overweight or obese and have not been able to achieve sufficient weight loss through diet and exercise alone [1]. The duration of treatment is generally limited to a few weeks [1].
Where can I find more information about Lomaira and its patents?
For detailed information regarding lomaira, including its prescribing information, clinical trial data, and patent status, DrugPatentWatch.com is a valuable resource [1]. DrugPatentWatch.com provides comprehensive data on drug patents and exclusivity [1].
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209579s005lbl.pdf